TABLE 1 Global Nonalcoholic Steatohepatitis (NASH) Treatment Market By Drug Type, 2022-2032, USD (Million)
TABLE 2 Global Nonalcoholic Steatohepatitis (NASH) Treatment Market By End-Use, 2022-2032, USD (Million)
TABLE 3 North America Nonalcoholic Steatohepatitis (NASH) Treatment Market By Drug Type, 2022-2032, USD (Million)
TABLE 4 North America Nonalcoholic Steatohepatitis (NASH) Treatment Market By End-Use, 2022-2032, USD (Million)
TABLE 5 U.S. Nonalcoholic Steatohepatitis (NASH) Treatment Market By Drug Type, 2022-2032, USD (Million)
TABLE 6 U.S. Nonalcoholic Steatohepatitis (NASH) Treatment Market By End-Use, 2022-2032, USD (Million)
TABLE 7 Canada Nonalcoholic Steatohepatitis (NASH) Treatment Market By Drug Type, 2022-2032, USD (Million)
TABLE 8 Canada Nonalcoholic Steatohepatitis (NASH) Treatment Market By End-Use, 2022-2032, USD (Million)
TABLE 9 Rest of North America Nonalcoholic Steatohepatitis (NASH) Treatment Market By Drug Type, 2022-2032, USD (Million)
TABLE 10 Rest of North America Nonalcoholic Steatohepatitis (NASH) Treatment Market By End-Use, 2022-2032, USD (Million)
TABLE 11 UK and European Union Nonalcoholic Steatohepatitis (NASH) Treatment Market By Drug Type, 2022-2032, USD (Million)
TABLE 12 UK and European Union Nonalcoholic Steatohepatitis (NASH) Treatment Market By End-Use, 2022-2032, USD (Million)
TABLE 13 UK Nonalcoholic Steatohepatitis (NASH) Treatment Market By Drug Type, 2022-2032, USD (Million)
TABLE 14 UK Nonalcoholic Steatohepatitis (NASH) Treatment Market By End-Use, 2022-2032, USD (Million)
TABLE 15 Germany Nonalcoholic Steatohepatitis (NASH) Treatment Market By Drug Type, 2022-2032, USD (Million)
TABLE 16 Germany Nonalcoholic Steatohepatitis (NASH) Treatment Market By End-Use, 2022-2032, USD (Million)
TABLE 17 Spain Nonalcoholic Steatohepatitis (NASH) Treatment Market By Drug Type, 2022-2032, USD (Million)
TABLE 18 Spain Nonalcoholic Steatohepatitis (NASH) Treatment Market By End-Use, 2022-2032, USD (Million)
TABLE 19 Italy Nonalcoholic Steatohepatitis (NASH) Treatment Market By Drug Type, 2022-2032, USD (Million)
TABLE 20 Italy Nonalcoholic Steatohepatitis (NASH) Treatment Market By End-Use, 2022-2032, USD (Million)
TABLE 21 France Nonalcoholic Steatohepatitis (NASH) Treatment Market By Drug Type, 2022-2032, USD (Million)
TABLE 22 France Nonalcoholic Steatohepatitis (NASH) Treatment Market By End-Use, 2022-2032, USD (Million)
TABLE 23 Rest of Europe Nonalcoholic Steatohepatitis (NASH) Treatment Market By Drug Type, 2022-2032, USD (Million)
TABLE 24 Rest of Europe Nonalcoholic Steatohepatitis (NASH) Treatment Market By End-Use, 2022-2032, USD (Million)
TABLE 25 Asia Nonalcoholic Steatohepatitis (NASH) Treatment Market By Drug Type, 2022-2032, USD (Million)
TABLE 26 Asia Nonalcoholic Steatohepatitis (NASH) Treatment Market By End-Use, 2022-2032, USD (Million)
TABLE 27 China Nonalcoholic Steatohepatitis (NASH) Treatment Market By Drug Type, 2022-2032, USD (Million)
TABLE 28 China Nonalcoholic Steatohepatitis (NASH) Treatment Market By End-Use, 2022-2032, USD (Million)
TABLE 29 Japan Nonalcoholic Steatohepatitis (NASH) Treatment Market By Drug Type, 2022-2032, USD (Million)
TABLE 30 Japan Nonalcoholic Steatohepatitis (NASH) Treatment Market By End-Use, 2022-2032, USD (Million)
TABLE 31 India Nonalcoholic Steatohepatitis (NASH) Treatment Market By Drug Type, 2022-2032, USD (Million)
TABLE 32 India Nonalcoholic Steatohepatitis (NASH) Treatment Market By End-Use, 2022-2032, USD (Million)
TABLE 33 Australia Nonalcoholic Steatohepatitis (NASH) Treatment Market By Drug Type, 2022-2032, USD (Million)
TABLE 34 Australia Nonalcoholic Steatohepatitis (NASH) Treatment Market By End-Use, 2022-2032, USD (Million)
TABLE 35 South Korea Nonalcoholic Steatohepatitis (NASH) Treatment Market By Drug Type, 2022-2032, USD (Million)
TABLE 36 South Korea Nonalcoholic Steatohepatitis (NASH) Treatment Market By End-Use, 2022-2032, USD (Million)
TABLE 37 Latin America Nonalcoholic Steatohepatitis (NASH) Treatment Market By Drug Type, 2022-2032, USD (Million)
TABLE 38 Latin America Nonalcoholic Steatohepatitis (NASH) Treatment Market By End-Use, 2022-2032, USD (Million)
TABLE 39 Brazil Nonalcoholic Steatohepatitis (NASH) Treatment Market By Drug Type, 2022-2032, USD (Million)
TABLE 40 Brazil Nonalcoholic Steatohepatitis (NASH) Treatment Market By End-Use, 2022-2032, USD (Million)
TABLE 41 Mexico Nonalcoholic Steatohepatitis (NASH) Treatment Market By Drug Type, 2022-2032, USD (Million)
TABLE 42 Mexico Nonalcoholic Steatohepatitis (NASH) Treatment Market By End-Use, 2022-2032, USD (Million)
TABLE 43 Rest of Latin America Nonalcoholic Steatohepatitis (NASH) Treatment Market By Drug Type, 2022-2032, USD (Million)
TABLE 44 Rest of Latin America Nonalcoholic Steatohepatitis (NASH) Treatment Market By End-Use, 2022-2032, USD (Million)
TABLE 45 Middle East and Africa Nonalcoholic Steatohepatitis (NASH) Treatment Market By Drug Type, 2022-2032, USD (Million)
TABLE 46 Middle East and Africa Nonalcoholic Steatohepatitis (NASH) Treatment Market By End-Use, 2022-2032, USD (Million)
TABLE 47 GCC Nonalcoholic Steatohepatitis (NASH) Treatment Market By Drug Type, 2022-2032, USD (Million)
TABLE 48 GCC Nonalcoholic Steatohepatitis (NASH) Treatment Market By End-Use, 2022-2032, USD (Million)
TABLE 49 Africa Nonalcoholic Steatohepatitis (NASH) Treatment Market By Drug Type, 2022-2032, USD (Million)
TABLE 50 Africa Nonalcoholic Steatohepatitis (NASH) Treatment Market By End-Use, 2022-2032, USD (Million)
TABLE 51 Rest of Middle East and Africa Nonalcoholic Steatohepatitis (NASH) Treatment Market By Drug Type, 2022-2032, USD (Million)
TABLE 52 Rest of Middle East and Africa Nonalcoholic Steatohepatitis (NASH) Treatment Market By End-Use, 2022-2032, USD (Million)